NCT02069353

Augmented Multimodal Neurologic Monitoring in High Risk Survivors of Cardiac Arrest

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 4 (actual)
• Sponsor: Jonathan Elmer · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Cardiac arrest is the most common cause of death in the United States and as many as 590,000 Americans suffering a cardiac arrest each year. Despite advances in care, as many as 50 to 89% of patients who are resuscitated after a cardiac arrest die in the hospital. Brain injury is the most common cause of death and disability after cardiac arrest. The investigators use advanced brain monitoring in patients who are at high risk of death after cardiac arrest, with the goal of preventing ongoing brain injury. The most common problem the investigators have observed is low oxygen levels in the brain, which is often very difficult to treat. In this study, the investigators plan to use two additional brain monitors in the care of these high risk patients: a monitor for seizures and a monitor of the amount of blood flow in the brain. The investigators will use these to detect and treat potential causes of low brain oxygen levels. The main hypotheses are that electrical events in the brain such as seizures and "spreading depolarizations" will occur during times of low brain tissue oxygen level, and that treating these events and low blood flow will reduce the rate of low brain oxygen levels.

Conditions

• Cardiac Arrest

Interventions

Type	Name	Description
DEVICE	QFlow 500™ Perfusion Probe (Hemedex, Cambridge, MA)
DEVICE	Spencer Probe Depth Electrode (Ad-Tech Medical, Racine, WI)

Timeline

• Start date: 2015-07-01
• Primary completion: 2018-10-19
• Completion: 2018-10-19
• First posted: 2014-02-24
• Last updated: 2019-10-08
• Results posted: 2019-10-08

Locations

1 site across 1 country: United States